Paper41279441
mRNA vaccination overcomes hemozoin-mediated impairment of whole parasite vaccine efficacy for malaria.
Hassert M and 8 others. bioRxiv, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. mRNA vaccination overcomes hemozoin-mediated impairment of whole parasite vaccine efficacy for malaria. Papers, record 41279441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41279441
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- mRNA vaccination overcomes hemozoin-mediated impairment of whole parasite vaccine efficacy for malaria.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants19
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R21 EY034198 | NEI NIH HHS | United States | R21EY034198 | PubMed and NIH | NIH RePORTER |
| T32 AI007260 | NIAID NIH HHS | United States | T32AI007260 | PubMed and NIH | NIH RePORTER |
| R01 AI100527 | NIAID NIH HHS | United States | R01AI100527 | PubMed and NIH | NIH RePORTER |
| P30 ES005605 | NIEHS NIH HHS | United States | P30ES005605 | PubMed and NIH | NIH RePORTER |
| T32 GM139776 | NIGMS NIH HHS | United States | T32GM139776 | PubMed and NIH | NIH RePORTER |
| R01 AI167847 | NIAID NIH HHS | United States | R01AI167847 | PubMed and NIH | NIH RePORTER |
| K99 AI190129 | NIAID NIH HHS | United States | K99AI190129 | PubMed and NIH | NIH RePORTER |
| R21 AI042767 | NIAID NIH HHS | United States | R01AI042767 | PubMed and NIH | NIH RePORTER |
| R01 AI114543 | NIAID NIH HHS | United States | R01AI114543 | PubMed and NIH | NIH RePORTER |
| F32 AI167088 | NIAID NIH HHS | United States | F32AI167088 | PubMed and NIH | NIH RePORTER |
| R37 AI042767 | NIAID NIH HHS | United States | R01AI042767 | PubMed and NIH | NIH RePORTER |
| F32 AI174382 | NIAID NIH HHS | United States | F32AI174382 | PubMed and NIH | NIH RePORTER |
| P30 CA086862 | NCI NIH HHS | United States | P30CA086862 | PubMed and NIH | NIH RePORTER |
| R01 AI042767 | NIAID NIH HHS | United States | R01AI042767 | PubMed and NIH | NIH RePORTER |
| R21 ES032937 | NIEHS NIH HHS | United States | R21ES032937 | PubMed and NIH | NIH RePORTER |
| R21 DE031042 | NIDCR NIH HHS | United States | R21DE031042 | PubMed and NIH | NIH RePORTER |
| R01 AI185725 | NIAID NIH HHS | United States | R01AI185725 | PubMed and NIH | NIH RePORTER |
| R21AI042767 | NIH | NIH RePORTER | |||
| R37AI042767 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Updated in | 41629565 | mRNA vaccination overcomes haemozoin-mediated impairment of whole-parasite malaria vaccines in mice. | https://conductscience.org/library/papers/41629565 |
Source PubMed
References74
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30127085 | Prime-and-Trap Malaria Vaccination To Generate Protective CD8+ Liver-Resident Memory T Cells. | J Immunol | 2018 | https://conductscience.org/library/papers/30127085 | PubMed |
| 2 | 31300331 | Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial. | Lancet Infect Dis | 2019 | https://conductscience.org/library/papers/31300331 | PubMed |
| 3 | 10762410 | Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. | Immunol Cell Biol | 2000 | https://conductscience.org/library/papers/10762410 | PubMed |
| 4 | 33674759 | COVID-19 vaccines: modes of immune activation and future challenges. | Nat Rev Immunol | 2021 | https://conductscience.org/library/papers/33674759 | PubMed |
| 5 | 32714882 | Plasmodium Impairs Antibacterial Innate Immunity to Systemic Infections in Part Through Hemozoin-Bound Bioactive Molecules. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/32714882 | PubMed |
| 6 | 10903750 | The complexity of protective immunity against liver-stage malaria. | J Immunol | 2000 | https://conductscience.org/library/papers/10903750 | PubMed |
| 7 | 23937890 | The hemozoin conundrum: is malaria pigment immune-activating, inhibiting, or simply a bystander? | Trends Parasitol | 2013 | https://conductscience.org/library/papers/23937890 | PubMed |
| 8 | 22567535 | In Vivo Hemozoin Kinetics after Clearance of Plasmodium berghei Infection in Mice. | Malar Res Treat | 2012 | https://conductscience.org/library/papers/22567535 | PubMed |
| 9 | 23907956 | Immunopathological effects of malaria pigment or hemozoin and other crystals. | Biofactors | 2014 | https://conductscience.org/library/papers/23907956 | PubMed |
| 10 | 27262417 | Malaria vaccines and human immune responses. | Curr Opin Microbiol | 2016 | https://conductscience.org/library/papers/27262417 | PubMed |
| 11 | 26858424 | Composition of the gut microbiota modulates the severity of malaria. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/26858424 | PubMed |
| 12 | 35096512 | Hemozoin: a Complex Molecule with Complex Activities. | Curr Clin Microbiol Rep | 2021 | https://conductscience.org/library/papers/35096512 | PubMed |
| 13 | 15630134 | Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. | J Exp Med | 2005 | https://conductscience.org/library/papers/15630134 | PubMed |
| 14 | 24825778 | Correlates of protective immunity following whole sporozoite vaccination against malaria. | Immunol Res | 2014 | https://conductscience.org/library/papers/24825778 | PubMed |
| 15 | 27084099 | Discriminating Protective from Nonprotective Plasmodium-Specific CD8+ T Cell Responses. | J Immunol | 2016 | https://conductscience.org/library/papers/27084099 | PubMed |
| 16 | 36159849 | Five decades of clinical assessment of whole-sporozoite malaria vaccines. | Front Immunol | 2022 | https://conductscience.org/library/papers/36159849 | PubMed |
| 17 | 37474653 | mRNA vaccine against malaria tailored for liver-resident memory T cells. | Nat Immunol | 2023 | https://conductscience.org/library/papers/37474653 | PubMed |
| 18 | 32566259 | Malaria vaccines since 2000: progress, priorities, products. | NPJ Vaccines | 2020 | https://conductscience.org/library/papers/32566259 | PubMed |
| 19 | 10432044 | A retrospective examination of the patterns of recrudescence in patients infected with Plasmodium falciparum. | Am J Trop Med Hyg | 1999 | https://conductscience.org/library/papers/10432044 | PubMed |
| 20 | 17261807 | Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17261807 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41279441
GET https://conductscience.org/api/papers/v1/41279441/references?page=2